<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JULY 17, 2000
REGISTRATION NO. 333-
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
deCODE genetics, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
<TABLE>
<S> <C> <C>
DELAWARE 8731 04-3326704
(State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer
Incorporation or Organization) Classification Code Number) Identification No.)
</TABLE>
------------------------
<TABLE>
<S> <C>
LYNGHALS 1 KARI STEFANSSON, M.D., DR. MED.
REYKJAVIK, ICELAND C/O SMITH, STRATTON, WISE, HEHER & BRENNAN
+ 354-570-1900 600 COLLEGE ROAD EAST
(Address, Including Zip Code, and Telephone PRINCETON, NEW JERSEY 08540
Number, Including Area Code, of Registrant's 609-924-6000
Principal Executive Office) (Name, Address, Including Zip Code, and Telephone
Number, Including Area Code, of Agent for Service)
</TABLE>
------------------------
Copies to:
<TABLE>
<S> <C>
DIANE M. FRENIER, ESQ. PAUL E. KUMLEBEN, ESQ.
MARSHA E. NOVICK, ESQ. DAVIS POLK & WARDWELL
SMITH, STRATTON, WISE, HEHER & BRENNAN 99 Gresham Street
600 College Road East London EC2V 7NG
Princeton, New Jersey 08540 United Kingdom
609-924-6000 + 44-207-418-1300
</TABLE>
------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
AS SOON AS POSSIBLE AFTER THE EFFECTIVE DATE OF THIS REGISTRATION STATEMENT
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [X] 333-31984
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
------------------------
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------
PROPOSED MAXIMUM PROPOSED MAXIMUM
TITLE OF EACH CLASS OF AMOUNT TO BE OFFERING PRICE AGGREGATE AMOUNT OF
SECURITIES TO BE REGISTERED REGISTERED PER SHARE OFFERING PRICE(1) REGISTRATION FEE
-----------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Common Stock, $.001 par value... 1,840,000 shares $18 $33,120,000 $8,743.68
-----------------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) Estimated solely for purposes of calculating the registration fee
pursuant to Rule 457 under the Securities Act of 1933, as amended.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
<PAGE> 2
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
This Registration Statement is being filed with the Securities and Exchange
Commission pursuant to Rule 462(b) under the Securities Act of 1933, as amended.
This Registration Statement relates to the public offering of Common Stock of
the Registrant contemplated by the Registration Statement on Form S-1, File No.
333-31984 declared effective July 17, 2000 (the "Prior Registration Statement"),
and is being filed for the sole purpose of registering additional securities of
the same class as were included in the Prior Registration Statement. The
contents of the Prior Registration Statement are hereby incorporated by
reference.
EXHIBITS
The following documents are filed as exhibits to this Registration
Statement:
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
------- ------------------------------------------------------------
<C> <S>
5.1 Opinion of Smith, Stratton, Wise, Heher & Brennan
8.1 Opinion of Stibbe Simont Monahan Duhot regarding Belgian
taxation
23.1 Consent of PricewaterhouseCoopers ehf., independent public
accountants
23.2 Consent of Smith, Stratton, Wise, Heher & Brennan (contained
in Exhibit 5.1)
23.3 Consent of Stibbe Simont Monahan Duhot (contained in Exhibit
8.1)
</TABLE>
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, we have duly
caused this registration statement to be signed on our behalf by the
undersigned, thereunto duly authorized, in the city of Reykjavik, Iceland, on
July 17, 2000.
deCODE genetics, Inc.
/s/ DR. KARI STEFANSSON
By:
--------------------------------------
Dr. Kari Stefansson,
Chairman, President and
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates stated.
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/ DR. KARI STEFANSSON Chairman, President, Chief Executive July 17, 2000
--------------------------------------------- Officer (principal executive officer)
Dr. Kari Stefansson and Director
/s/ AXEL NIELSEN Vice President, Finance and Treasurer July 17, 2000
--------------------------------------------- (principal financial officer and
Axel Nielsen principal accounting officer)
* Director July 17, 2000
---------------------------------------------
Jean-Francois Formela
* Director July 17, 2000
---------------------------------------------
Andre Lamotte
* Director July 17, 2000
---------------------------------------------
Terrance McGuire
* Director July 17, 2000
---------------------------------------------
Guy Nohra
* Director July 17, 2000
---------------------------------------------
Sir John Vane
</TABLE>
* By his signature set forth below, the undersigned, pursuant to duly authorized
powers of attorney filed with the Securities and Exchange Commission, has
signed this registration statement on behalf of persons indicated.
By: /s/ KARI STEFANSSON
--------------------------------------------
Kari Stefansson, M.D., Dr. Med.
Attorney-in-fact
<PAGE> 4
INDEX OF EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
------- ------------------------------------------------------------
<C> <S>
5.1 Opinion of Smith, Stratton, Wise, Heher & Brennan
8.1 Opinion of Stibbe Simont Monahan Duhot regarding Belgian
taxation
23.1 Consent of PricewaterhouseCoopers ehf., independent public
accountants
23.2 Consent of Smith, Stratton, Wise, Heher & Brennan (contained
in Exhibit 5.1)
23.3 Consent of Stibbe Simont Monahan Duhot (contained in Exhibit
8.1)
</TABLE>
